Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Royalty Pharma plc (RPRX) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $39.30 Metrics
OS: 601.8 M
Market cap: $23.7 B
Net debt: $4.6 B
EV: $28.3 B

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
Revenues2,289.52,122.41,814.31,794.91,597.9
            Revenue growth7.9%17.0%1.1%12.3% 
Cost of goods sold452.8230.8-1,019.3430.4453.4
Gross profit1,836.61,891.52,833.61,364.41,144.5
            Gross margin80.2%89.1%156.2%76.0%71.6%
Research and development200.126.383.0392.6117.9
General and administrative182.8181.7103.461.9106.4
EBITA1,434.21,662.92,614.61,390.71,084.0
            EBITA margin62.6%78.4%144.1%77.5%67.8%
Amortization of intangibles23.023.123.933.333.3
EBIT1,411.21,639.92,590.71,357.41,050.7
            EBIT margin61.6%77.3%142.8%75.6%65.8%
Pre-tax income1,241.21,702.02,461.41,517.91,343.2
Income taxes0.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%
Net income619.7975.02,348.51,377.71,210.0
            Net margin27.1%45.9%129.4%76.8%75.7%
 
Diluted EPS$1.49$2.60   
Shares outstanding (diluted)414.8375.5   
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy